Journal of Applied Physiology AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 64: 2532-2537, 1988;
8750-7587/88 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minette, P. A.
Right arrow Articles by Barnes, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minette, P. A.
Right arrow Articles by Barnes, P. J.

Journal of Applied Physiology, Vol 64, Issue 6 2532-2537, Copyright © 1988 by American Physiological Society


ARTICLES

Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways

P. A. Minette and P. J. Barnes
Department of Thoracic Medicine, Cardiothoracic Institute, London, United Kingdom.

We have investigated whether prejunctional inhibitory muscarinic receptors ("autoreceptors") exist on cholinergic nerves in human airways in vitro and whether guinea pig trachea provides a good model for further pharmacological characterization of these receptors. Pilocarpine was used as a selective agonist and gallamine as a selective antagonist of these autoreceptors. Acetylcholine (ACh) release from postganglionic cholinergic nerves was elicited by electrical field stimulation (EFS) (40 V, 0.5 ms, 32 Hz). In human bronchi, pilocarpine inhibited the contractile response to EFS in a dose-related fashion; the dose inhibiting 50% of the control contraction was 2.2 +/- 0.4 x 10(-7) (SE) M (n = 22), and the inhibition was 96% at 3 x 10(-5) M. The inhibitory effects of pilocarpine were antagonized by gallamine in a dose-related fashion. The results were qualitatively the same in the guinea pig. Gallamine significantly enhanced the contractile response to EFS in the guinea pig, whereas pirenzepine failed to do so, which suggests that M2-receptors are involved. We conclude that prejunctional muscarinic receptors that inhibit ACh release are present on cholinergic nerves in human airways and that guinea pig trachea is a good model for further pharmacological characterization of these receptors, which appear to belong to the M2-subtype.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
N. Durcan, R. W. Costello, W. G. McLean, J. Blusztajn, B. Madziar, A. G. Fenech, I. P. Hall, G. J. Gleich, L. McGarvey, and M.-T. Walsh
Eosinophil-Mediated Cholinergic Nerve Remodeling
Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 775 - 786.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
B. J. Proskocil and A. D. Fryer
{beta}2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease
Proceedings of the ATS, November 1, 2005; 2(4): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Johnson
Corticosteroids: Potential {beta}2-Agonist and Anticholinergic Interactions in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 320 - 325.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. J. Lein and A. D. Fryer
Organophosphorus Insecticides Induce Airway Hyperreactivity by Decreasing Neuronal M2 Muscarinic Receptor Function Independent of Acetylcholinesterase Inhibition
Toxicol. Sci., January 1, 2005; 83(1): 166 - 176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. M. Lee, A. D. Fryer, N. van Rooijen, and D. B. Jacoby
Role of macrophages in virus-induced airway hyperresponsiveness and neuronal M2 muscarinic receptor dysfunction
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1255 - L1259.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. D. Fryer, P. J. Lein, A. S. Howard, B. L. Yost, R. A. Beckles, and D. A. Jett
Mechanisms of organophosphate insecticide-induced airway hyperreactivity
Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L963 - L969.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. R. Coulson, D. B. Jacoby, and A. D. Fryer
Insulin Regulates Neuronal M2 Muscarinic Receptor Function in the Ileum of Diabetic Rats
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. J. Adamko, A. D. Fryer, B. S. Bochner, and D. B. Jacoby
CD8+ T Lymphocytes in Viral Hyperreactivity and M2 Muscarinic Receptor Dysfunction
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 550 - 556.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Sarria, E. Naline, Y. Zhang, J. Cortijo, M. Molimard, J. Moreau, P. Therond, C. Advenier, and E. J. Morcillo
Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1125 - L1132.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. B. Jacoby
Virus-Induced Asthma Attacks
JAMA, February 13, 2002; 287(6): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Hirose, I. Aoki, T. Kimura, T. Fujikawa, T. Numazawa, K. Sasaki, A. Sato, T. Hasegawa, M. Nishikibe, M. Mitsuya, et al.
Pharmacological Properties of (2R)-N-[1-(6-Aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2- hydroxy-2-phenylacetamide: A Novel Muscarinic Antagonist with M2-Sparing Antagonistic Activity
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 790 - 797.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. B. Jacoby, B. L. Yost, B. Kumaravel, Y. Chan-Li, H.-Q. Xiao, K. Kawashima, and A. D. Fryer
Glucocorticoid Treatment Increases Inhibitory M2 Muscarinic Receptor Expression and Function in the Airways
Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 485 - 491.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. M. Evans, K. E. Belmonte, R. W. Costello, D. B. Jacoby, G. J. Gleich, and A. D. Fryer
Substance P-induced airway hyperreactivity is mediated by neuronal M2 receptor dysfunction
Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L477 - L486.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. J. Adamko, B. L. Yost, G. J. Gleich, A. D. Fryer, and D. B. Jacoby
Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection: Eosinophils Mediate Airway Hyperresponsiveness, M2 Muscarinic Receptor Dysfunction, and Antiviral Effects
J. Exp. Med., November 15, 1999; 190(10): 1465 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. L. Yost, G. J. Gleich, and A. D. Fryer
Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein
J Appl Physiol, October 1, 1999; 87(4): 1272 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. D. FRYER and D. B. JACOBY
Muscarinic Receptors and Control of Airway Smooth Muscle
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S154 - S160.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R W Costello, D B Jacoby, and A D Fryer
Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity
Thorax, July 1, 1998; 53(7): 613 - 618.
[Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Fryer, Y.-C. Huang, G. Rao, D. Jacoby, E. Mancilla, R. Whorton, C. A. Piantadosi, T. Kennedy, and J. Hoidal
Selective O-Desulfation Produces Nonanticoagulant Heparin that Retains Pharmacological Activity in the Lung,
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 208 - 219.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online